3SBio Inc. Announces Filing of Annual Report on Form 20-F

SHENYANG, China, July 2 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. , a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has filed with the SEC an annual report on Form 20-F for the year ended December 31, 2006. Copies of the report are available for download under the Investors page on the Company’s website at http://bbs.3sbio.com/en/News/ShowInfo_n16.aspx?ID=30 .

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at http://www.3sbio.com .

For more information, please contact Investor Contact: Clara Mak, CFO 3SBio Inc. Tel: +86-24-2581-1820 Email: ir@3sbio.com Investor Relations (HK): Ruby Yim Taylor Rafferty Tel: +852-3196-3712 Email: 3sbio@taylor-rafferty.com Investor Relations (US): Mahmoud Siddig Taylor Rafferty Tel: +1-212-889-4350 Email: 3sbio@taylor-rafferty.com Media Contact: John Dooley Taylor Rafferty Tel: +1-212-889-4350 Email: 3sbio@taylor-rafferty.com

3SBio Inc.

CONTACT: Investor Contact -- Clara Mak, CFO of 3SBio Inc.,+86-24-2581-1820, or ir@3sbio.com; or Investor Relations (HK) -- Ruby Yim,+852-3196-3712, or Investor Relations (US) -- Mahmoud Siddig,+1-212-889-4350, or Media Contact -- John Dooley, +1-212-889-4350, all ofTaylor Rafferty, 3sbio@taylor-rafferty.com, for 3Sbio

MORE ON THIS TOPIC